POSTED BY gene2know | Oct, 22, 2018 |

In the recent past, research has suggested that there is considerable confusion and uncertainty in the healthcare industry. One of the primary considerations has been the access to quality healthcare. The problems with access have usually been linked to the cost of services. Research has also reflected that there has been a rise in physician retirements, practice sales and closures over the past decade. These factors contribute to another disturbing trend: delay of treatment. With fewer practitioners available appointments are more difficult to secure. Because of this more responsibility is being placed directly upon consumers to become more informed and involved in healthcare decisions for themselves and their families. However, the quality of any decisions made is dependent upon the nature of the information available. Modern genetic testing can now provide critical information that was previously unavailable. It serves as an additional, accessible, and affordable resource for consumers reducing any guesswork that could delay treatment.

Before they see you healthcare providers typically want to know your history as well as your family’s history. Although they are looking for trends and common links, genetic testing provides more definitive information to healthcare providers. It provides more valid and reliable information than that obtained by recall and self-report. Given the limitations and uncertainty of our healthcare systems, you can no longer afford to be a passive spectator to your own health and healthcare. With recent advances in research and technology, you can assume more of a sense of control by staying informed about your unique genetic profile. You can put yourself on the cutting edge of the science that specifically applies to you by being better informed. A Gene2Know genetic profile* makes you an active participant in your own healthcare as part of your own personal treatment team.

A decade ago, genetic testing was only available to very a select few. Such testing required a prescription and was prohibitively expensive. The testing also required tissue samples usually in the form of a blood test. Collectively, these factors presented significant resistance to testing. Approximately ten years ago the technology advanced so that an easy, convenient, and painless saliva sample became all that is necessary to obtain a genetic profile. This sample collection method has overcome much of the resistance to genetic testing. All personal information remains absolutely secure and confidential by being stored separate from the sample profile, which helps to address any safety and security concerns.

Most people have become accustomed to adopting a passive role when visiting healthcare providers. They are content to follow doctors’ orders without question. With the knowledge acquired from a Gene2Know genetic profile, you can become an active participant as part of your own personal treatment team. You can no longer afford to be left out of critical healthcare decisions. With recent advances in research and technology, there is no need to settle for not knowing. With your unique profile, there is far less guesswork that could delay treatment. The additional information from the profiles allow healthcare providers to be more timely, definitive, and specific when diagnosing, prescribing, and treating. Surveys have suggested strong support and acceptance of genetic home testing results as valued additions to their patient files. You gain more control by staying informed about your family’s unique genetic profiles.

The G2K Mobile App provides instant access to your unique personal genetic profile reports. To overcome the difficulties caused by access, cost, and timeliness of healthcare, experience the speed and convenience of the Gene2Know app and scanner instantly available through your smart device. Questions and problems can develop at any time and any place. For any questions about your own personal history and lifestyle, you have instant access to the Gene2Know database for immediate answers from the convenience of your smartphone. Regardless of where you are you can experience the speed and convenience of the mobile app and scanner. You have immediate access to your reports through the mobile app at any time, day or night. The extensive Pharmocogenomic (PGx) databases are constantly being updated as more medications and supplements are placed on the market. The app instantly compares over 50,000 medications, vitamins, and supplements for compatibility with your unique genetic profile. This convenience lets you scan products for relevant content. The Gene2Know app can also forward your information directly to your healthcare providers for faster, more accurate diagnoses, prescriptions, and treatments. Together with this speed and convenience, proven safety and security measures ensure that all of your personal information remains absolutely secure and confidential.

*Requires purchase of G2K PGx medication report


The challenges of implementing Pharmacogenomic testing in the clinic. Moyer AM; Caraballo PJ, Expert Review of Pharmacoeconomics & Outcomes Research [Expert Rev Pharmacoecon Outcomes Res], ISSN: 1744-8379, 2017 Dec.

Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Lemke, Amy A.; Hulick, Peter J.; Wake, Dyson T.; Sereika, Annette W.; Yu, Kristen Dilzell; Glaser, Nicole S.; Dunnenberger, Henry M.; Wang, Chi. PHARMACOGENOMICS; MAR 2018

Exploring public genomics data for population pharmacogenomics. Lakiotaki, Kleanthi; Kanterakis, Alexandros; Kartsaki, Evgenia; Katsila, Theodora; Patrinos, George P.; Potamias, George. PLoS ONE. 8/3/2017, Vol. 12 Issue 8, p1-18.

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians. Jones, Laney K.; Rahm, Alanna Kulchak; Gionfriddo, Michael R.; Williams, Janet L.; Fan, Audrey L.; Pulk, Rebecca A.; Wright, Eric A.; Williams, Marc S.. CTS-CLINICAL AND TRANSLATIONAL SCIENCE; MAY 2018.

Updating the landscape of direct-to-consumer Pharmacogenomic testing. Filipski KK; Murphy JD; Helzlsouer KJ. In: Pharmacogenomics and Personalized Medicine, Vol Volume 10, Pp 229-232 (2017); Dove Medical Press, 2017.

Patterns of Medication Use in the United States. Boston University, Slone Epidemiology Center. 2006.

Attitudes of clinicians following large-scale pharmacogenomics implementation. Peterson JF; Field JR; Shi Y; Schildcrout JS; Denny JC; McGregor TL; Van Driest SL; Pulley JM; Lubin IM; Laposata M; Roden DM; Clayton EW, The Pharmacogenomics Journal [Pharmacogenomics J], ISSN: 1473-1150, 2016 Aug.


  • DNA,
  • DNA Testing,
  • healthcare,
  • Pharmacogenomics,